1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global EPO Biomarkers Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Erythropoietin alfa 1.2.3 Erythropoietin beta 1.2.4 Erythropoietin zeta 1.2.5 Erythropoietin theta 1.2.6 Recombinant human erythropoietin 1.2.7 Darbepoietin alfa 1.3 Market by Application 1.3.1 Global EPO Biomarkers Market Share by Application: 2020 VS 2026 1.3.2 Diagnostic centers 1.3.3 Ambulatory care and surgical centers 1.3.4 Hospitals 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global EPO Biomarkers Market Perspective (2015-2026) 2.2 Global EPO Biomarkers Growth Trends by Regions 2.2.1 EPO Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 EPO Biomarkers Historic Market Share by Regions (2015-2020) 2.2.3 EPO Biomarkers Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top EPO Biomarkers Players by Market Size 3.1.1 Global Top EPO Biomarkers Players by Revenue (2015-2020) 3.1.2 Global EPO Biomarkers Revenue Market Share by Players (2015-2020) 3.2 Global EPO Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by EPO Biomarkers Revenue 3.4 Global EPO Biomarkers Market Concentration Ratio 3.4.1 Global EPO Biomarkers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by EPO Biomarkers Revenue in 2019 3.5 Key Players EPO Biomarkers Area Served 3.6 Key Players EPO Biomarkers Product Solution and Service 3.7 Date of Enter into EPO Biomarkers Market 3.8 Mergers & Acquisitions, Expansion Plans 4 EPO Biomarkers Breakdown Data by Type (2015-2026) 4.1 Global EPO Biomarkers Historic Market Size by Type (2015-2020) 4.2 Global EPO Biomarkers Forecasted Market Size by Type (2021-2026) 5 EPO Biomarkers Breakdown Data by Application (2015-2026) 5.1 Global EPO Biomarkers Historic Market Size by Application (2015-2020) 5.2 Global EPO Biomarkers Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America EPO Biomarkers Market Size (2015-2026) 6.2 North America EPO Biomarkers Market Size by Type (2015-2020) 6.3 North America EPO Biomarkers Market Size by Application (2015-2020) 6.4 North America EPO Biomarkers Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe EPO Biomarkers Market Size (2015-2026) 7.2 Europe EPO Biomarkers Market Size by Type (2015-2020) 7.3 Europe EPO Biomarkers Market Size by Application (2015-2020) 7.4 Europe EPO Biomarkers Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China EPO Biomarkers Market Size (2015-2026) 8.2 China EPO Biomarkers Market Size by Type (2015-2020) 8.3 China EPO Biomarkers Market Size by Application (2015-2020) 8.4 China EPO Biomarkers Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan EPO Biomarkers Market Size (2015-2026) 9.2 Japan EPO Biomarkers Market Size by Type (2015-2020) 9.3 Japan EPO Biomarkers Market Size by Application (2015-2020) 9.4 Japan EPO Biomarkers Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia EPO Biomarkers Market Size (2015-2026) 10.2 Southeast Asia EPO Biomarkers Market Size by Type (2015-2020) 10.3 Southeast Asia EPO Biomarkers Market Size by Application (2015-2020) 10.4 Southeast Asia EPO Biomarkers Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Siemens 11.1.1 Siemens Company Details 11.1.2 Siemens Business Overview 11.1.3 Siemens EPO Biomarkers Introduction 11.1.4 Siemens Revenue in EPO Biomarkers Business (2015-2020)) 11.1.5 Siemens Recent Development 11.2 Thermo Fisher Scientific 11.2.1 Thermo Fisher Scientific Company Details 11.2.2 Thermo Fisher Scientific Business Overview 11.2.3 Thermo Fisher Scientific EPO Biomarkers Introduction 11.2.4 Thermo Fisher Scientific Revenue in EPO Biomarkers Business (2015-2020) 11.2.5 Thermo Fisher Scientific Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer EPO Biomarkers Introduction 11.3.4 Pfizer Revenue in EPO Biomarkers Business (2015-2020) 11.3.5 Pfizer Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis EPO Biomarkers Introduction 11.4.4 Novartis Revenue in EPO Biomarkers Business (2015-2020) 11.4.5 Novartis Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson EPO Biomarkers Introduction 11.5.4 Johnson & Johnson Revenue in EPO Biomarkers Business (2015-2020) 11.5.5 Johnson & Johnson Recent Development 11.6 Merck 11.6.1 Merck Company Details 11.6.2 Merck Business Overview 11.6.3 Merck EPO Biomarkers Introduction 11.6.4 Merck Revenue in EPO Biomarkers Business (2015-2020) 11.6.5 Merck Recent Development 11.7 LG Life Sciences India 11.7.1 LG Life Sciences India Company Details 11.7.2 LG Life Sciences India Business Overview 11.7.3 LG Life Sciences India EPO Biomarkers Introduction 11.7.4 LG Life Sciences India Revenue in EPO Biomarkers Business (2015-2020) 11.7.5 LG Life Sciences India Recent Development 11.8 Amgen 11.8.1 Amgen Company Details 11.8.2 Amgen Business Overview 11.8.3 Amgen EPO Biomarkers Introduction 11.8.4 Amgen Revenue in EPO Biomarkers Business (2015-2020) 11.8.5 Amgen Recent Development 11.9 Roche 11.9.1 Roche Company Details 11.9.2 Roche Business Overview 11.9.3 Roche EPO Biomarkers Introduction 11.9.4 Roche Revenue in EPO Biomarkers Business (2015-2020) 11.9.5 Roche Recent Development 11.10 Agilent 11.10.1 Agilent Company Details 11.10.2 Agilent Business Overview 11.10.3 Agilent EPO Biomarkers Introduction 11.10.4 Agilent Revenue in EPO Biomarkers Business (2015-2020) 11.10.5 Agilent Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global EPO Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Erythropoietin alfa Table 4. Key Players of Erythropoietin beta Table 5. Key Players of Erythropoietin zeta Table 6. Key Players of Erythropoietin theta Table 7. Key Players of Recombinant human erythropoietin Table 8. Key Players of Darbepoietin alfa Table 9. Global EPO Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global EPO Biomarkers Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global EPO Biomarkers Market Size by Regions (2015-2020) (US$ Million) Table 12. Global EPO Biomarkers Market Share by Regions (2015-2020) Table 13. Global EPO Biomarkers Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global EPO Biomarkers Market Share by Regions (2021-2026) Table 15. EPO Biomarkers Market Market Trends Table 16. EPO Biomarkers Market Drivers Table 17. EPO Biomarkers Market Challenges Table 18. EPO Biomarkers Market Restraints Table 19. Global EPO Biomarkers Revenue by Players (2015-2020) (US$ Million) Table 20. Global EPO Biomarkers Market Share by Players (2015-2020) Table 21. Global Top EPO Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EPO Biomarkers as of 2019) Table 22. Global EPO Biomarkers by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players EPO Biomarkers Product Solution and Service Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global EPO Biomarkers Market Size by Type (2015-2020) (US$ Million) Table 27. Global EPO Biomarkers Market Size Share by Type (2015-2020) Table 28. Global EPO Biomarkers Revenue Market Share by Type (2021-2026) Table 29. Global EPO Biomarkers Market Size Share by Application (2015-2020) Table 30. Global EPO Biomarkers Market Size by Application (2015-2020) (US$ Million) Table 31. Global EPO Biomarkers Market Size Share by Application (2021-2026) Table 32. North America EPO Biomarkers Market Size by Type (2015-2020) (US$ Million) Table 33. North America EPO Biomarkers Market Share by Type (2015-2020) Table 34. North America EPO Biomarkers Market Size by Application (2015-2020) (US$ Million) Table 35. North America EPO Biomarkers Market Share by Application (2015-2020) Table 36. North America EPO Biomarkers Market Size by Country (US$ Million) (2015-2020) Table 37. North America EPO Biomarkers Market Share by Country (2015-2020) Table 38. Europe EPO Biomarkers Market Size by Type (2015-2020) (US$ Million) Table 39. Europe EPO Biomarkers Market Share by Type (2015-2020) Table 40. Europe EPO Biomarkers Market Size by Application (2015-2020) (US$ Million) Table 41. Europe EPO Biomarkers Market Share by Application (2015-2020) Table 42. Europe EPO Biomarkers Market Size by Country (US$ Million) (2015-2020) Table 43. Europe EPO Biomarkers Market Share by Country (2015-2020) Table 44. China EPO Biomarkers Market Size by Type (2015-2020) (US$ Million) Table 45. China EPO Biomarkers Market Share by Type (2015-2020) Table 46. China EPO Biomarkers Market Size by Application (2015-2020) (US$ Million) Table 47. China EPO Biomarkers Market Share by Application (2015-2020) Table 48. China EPO Biomarkers Market Size by Region (US$ Million) (2015-2020) Table 49. China EPO Biomarkers Market Share by Region (2015-2020) Table 50. Japan EPO Biomarkers Market Size by Type (2015-2020) (US$ Million) Table 51. Japan EPO Biomarkers Market Share by Type (2015-2020) Table 52. Japan EPO Biomarkers Market Size by Application (2015-2020) (US$ Million) Table 53. Japan EPO Biomarkers Market Share by Application (2015-2020) Table 54. Japan EPO Biomarkers Market Size by Country (US$ Million) (2015-2020) Table 55. Japan EPO Biomarkers Market Share by Country (2015-2020) Table 56. Southeast Asia EPO Biomarkers Market Size by Type (2015-2020) (US$ Million) Table 57. Southeast Asia EPO Biomarkers Market Share by Type (2015-2020) Table 58. Southeast Asia EPO Biomarkers Market Size by Application (2015-2020) (US$ Million) Table 59. Southeast Asia EPO Biomarkers Market Share by Application (2015-2020) Table 60. Southeast Asia EPO Biomarkers Market Size by Country (US$ Million) (2015-2020) Table 61. Southeast Asia EPO Biomarkers Market Share by Country (2015-2020) Table 62. Siemens Company Details Table 63. Siemens Business Overview Table 64. Siemens Product Table 65. Siemens Revenue in EPO Biomarkers Business (2015-2020) (US$ Million) Table 66. Siemens Recent Development Table 67. Thermo Fisher Scientific Company Details Table 68. Thermo Fisher Scientific Business Overview Table 69. Thermo Fisher Scientific Product Table 70. Thermo Fisher Scientific Revenue in EPO Biomarkers Business (2015-2020) (US$ Million) Table 71. Thermo Fisher Scientific Recent Development Table 72. Pfizer Company Details Table 73. Pfizer Business Overview Table 74. Pfizer Product Table 75. Pfizer Revenue in EPO Biomarkers Business (2015-2020) (US$ Million) Table 76. Pfizer Recent Development Table 77. Novartis Company Details Table 78. Novartis Business Overview Table 79. Novartis Product Table 80. Novartis Revenue in EPO Biomarkers Business (2015-2020) (US$ Million) Table 81. Novartis Recent Development Table 82. Johnson & Johnson Company Details Table 83. Johnson & Johnson Business Overview Table 84. Johnson & Johnson Product Table 85. Johnson & Johnson Revenue in EPO Biomarkers Business (2015-2020) (US$ Million) Table 86. Johnson & Johnson Recent Development Table 87. Merck Company Details Table 88. Merck Business Overview Table 89. Merck Product Table 90. Merck Revenue in EPO Biomarkers Business (2015-2020) (US$ Million) Table 91. Merck Recent Development Table 92. LG Life Sciences India Company Details Table 93. LG Life Sciences India Business Overview Table 94. LG Life Sciences India Product Table 95. LG Life Sciences India Revenue in EPO Biomarkers Business (2015-2020) (US$ Million) Table 96. LG Life Sciences India Recent Development Table 97. Amgen Business Overview Table 98. Amgen Product Table 99. Amgen Company Details Table 100. Amgen Revenue in EPO Biomarkers Business (2015-2020) (US$ Million) Table 101. Amgen Recent Development Table 102. Roche Company Details Table 103. Roche Business Overview Table 104. Roche Product Table 105. Roche Revenue in EPO Biomarkers Business (2015-2020) (US$ Million) Table 106. Roche Recent Development Table 107. Agilent Company Details Table 108. Agilent Business Overview Table 109. Agilent Product Table 110. Agilent Revenue in EPO Biomarkers Business (2015-2020) (US$ Million) Table 111. Agilent Recent Development Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global EPO Biomarkers Market Share by Type: 2020 VS 2026 Figure 2. Erythropoietin alfa Features Figure 3. Erythropoietin beta Features Figure 4. Erythropoietin zeta Features Figure 5. Erythropoietin theta Features Figure 6. Recombinant human erythropoietin Features Figure 7. Darbepoietin alfa Features Figure 8. Global EPO Biomarkers Market Share by Application: 2020 VS 2026 Figure 9. Diagnostic centers Case Studies Figure 10. Ambulatory care and surgical centers Case Studies Figure 11. Hospitals Case Studies Figure 12. EPO Biomarkers Report Years Considered Figure 13. Global EPO Biomarkers Market Size (US$ Million), YoY Growth 2015-2026 Figure 14. Global EPO Biomarkers Market Share by Regions: 2020 VS 2026 Figure 15. Global EPO Biomarkers Market Share by Regions (2021-2026) Figure 16. Global EPO Biomarkers Market Share by Players in 2019 Figure 17. Global Top EPO Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EPO Biomarkers as of 2019 Figure 18. The Top 10 and 5 Players Market Share by EPO Biomarkers Revenue in 2019 Figure 19. North America EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. United States EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Canada EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Europe EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Germany EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. France EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. U.K. EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Italy EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Russia EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Nordic EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Rest of Europe EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Asia-Pacific EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. China EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Japan EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. South Korea EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Southeast Asia EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. India EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Australia EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Rest of Asia-Pacific EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Latin America EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Mexico EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Brazil EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Middle East & Africa EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Turkey EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Saudi Arabia EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. UAE EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Rest of Middle East & Africa EPO Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 46. Siemens Revenue Growth Rate in EPO Biomarkers Business (2015-2020) Figure 47. Thermo Fisher Scientific Revenue Growth Rate in EPO Biomarkers Business (2015-2020) Figure 48. Pfizer Revenue Growth Rate in EPO Biomarkers Business (2015-2020) Figure 49. Novartis Revenue Growth Rate in EPO Biomarkers Business (2015-2020) Figure 50. Johnson & Johnson Revenue Growth Rate in EPO Biomarkers Business (2015-2020) Figure 51. Merck Revenue Growth Rate in EPO Biomarkers Business (2015-2020) Figure 52. LG Life Sciences India Revenue Growth Rate in EPO Biomarkers Business (2015-2020) Figure 53. Amgen Revenue Growth Rate in EPO Biomarkers Business (2015-2020) Figure 54. Roche Revenue Growth Rate in EPO Biomarkers Business (2015-2020) Figure 55. Agilent Revenue Growth Rate in EPO Biomarkers Business (2015-2020) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Siemens Thermo Fisher Scientific Pfizer Novartis Johnson & Johnson Merck LG Life Sciences India Amgen Roche Agilent